Raymond James Financial Inc. Makes New $10.13 Million Investment in Surgery Partners, Inc. (NASDAQ:SGRY)

Raymond James Financial Inc. acquired a new stake in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 478,488 shares of the company's stock, valued at approximately $10,130,000. Raymond James Financial Inc. owned about 0.38% of Surgery Partners as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in SGRY. King Street Capital Management L.P. acquired a new stake in Surgery Partners during the 3rd quarter valued at $46,748,000. Janus Henderson Group PLC lifted its stake in shares of Surgery Partners by 27.5% during the 3rd quarter. Janus Henderson Group PLC now owns 5,497,368 shares of the company's stock worth $177,235,000 after buying an additional 1,184,450 shares during the last quarter. FMR LLC boosted its holdings in shares of Surgery Partners by 3.1% during the 3rd quarter. FMR LLC now owns 18,311,867 shares of the company's stock worth $590,375,000 after buying an additional 546,869 shares during the period. E. Ohman J or Asset Management AB grew its stake in Surgery Partners by 40.3% in the 4th quarter. E. Ohman J or Asset Management AB now owns 1,243,111 shares of the company's stock valued at $26,317,000 after buying an additional 357,023 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG bought a new position in Surgery Partners in the 3rd quarter valued at about $2,129,000.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the company. Royal Bank of Canada restated an "outperform" rating and set a $35.00 price objective on shares of Surgery Partners in a report on Tuesday. JPMorgan Chase & Co. decreased their price objective on Surgery Partners from $38.00 to $28.00 and set a "neutral" rating on the stock in a report on Tuesday, December 3rd. Bank of America initiated coverage on Surgery Partners in a report on Monday, December 16th. They set a "buy" rating and a $30.00 target price for the company. Finally, Macquarie lowered their price target on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 11th. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat, Surgery Partners has a consensus rating of "Moderate Buy" and a consensus target price of $36.63.

Remove Ads

Surgery Partners Trading Down 0.8 %

Shares of SGRY stock traded down $0.20 during mid-day trading on Tuesday, reaching $24.19. 838,849 shares of the stock traded hands, compared to its average volume of 1,062,562. The company has a market cap of $3.09 billion, a price-to-earnings ratio of -50.40, a price-to-earnings-growth ratio of 19.21 and a beta of 2.73. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99. The stock's fifty day simple moving average is $23.99 and its two-hundred day simple moving average is $25.69. Surgery Partners, Inc. has a 1-year low of $19.50 and a 1-year high of $33.97.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its earnings results on Monday, March 3rd. The company reported $0.39 EPS for the quarter, topping the consensus estimate of $0.38 by $0.01. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business had revenue of $864.40 million for the quarter, compared to the consensus estimate of $828.09 million. On average, research analysts anticipate that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CFO David T. Doherty sold 6,733 shares of the business's stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $24.02, for a total value of $161,726.66. Following the transaction, the chief financial officer now owns 150,868 shares in the company, valued at approximately $3,623,849.36. The trade was a 4.27 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Marissa Brittenham sold 3,156 shares of the company's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $24.09, for a total transaction of $76,028.04. Following the completion of the sale, the insider now directly owns 63,408 shares in the company, valued at approximately $1,527,498.72. This represents a 4.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 106,622 shares of company stock valued at $2,717,860 over the last 90 days. 2.30% of the stock is owned by insiders.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.